Text Size
5 studies found for:    alemtuzumab | Interventional Studies | multiple sclerosis | Phase 3

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Biological: alemtuzumab
2 Completed Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
3 Completed Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
4 Not yet recruiting Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Drug: Alemtuzumab
5 Enrolling by invitation Advanced MRI Measures of Repair in Alemtuzumab Treated Patients
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: MabCampath-1h
To Top

† Indicates status has not been verified in more than two years